Newsroom | 7665 results

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Paysafe Envision Formula E Team unveils its new livery, marking a new era with GEN4 technology....

NEW ALBANY, Ohio--(BUSINESS WIRE)--Bayer announced on Friday plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in New Albany, Ohio, U.S. Building on more than seven billion dollars in U.S. pharma R&D and manufacturing spend over the past five years, the project is a central element of Bayer’s long-term growth strategy and commitment to innovation and patient access in its largest pharmaceuticals market. “Bayer has long seen the United States as a key manufa...

HARRISON, N.Y.--(BUSINESS WIRE)--The NRP Group, a vertically integrated, best-in-class developer, builder and manager of multifamily housing, in partnership with RPW Group, today announced the completion and opening of One Webb Ave, a 200-unit luxury multifamily community in Harrison, New York. Designed with sustainability, wellness and connectivity in mind, One Webb Ave offers residents a high-quality living experience in one of Westchester County’s most desirable communities. The milestone wa...

SAN FRANCISCO--(BUSINESS WIRE)--Business Wire celebrates 65 years of global press release distribution and regulatory disclosure, highlighting its history and continued innovation....

OMAHA, Neb. & DES MOINES, Iowa--(BUSINESS WIRE)--Three U-Haul® Companies are offering 30 days of free self-storage and U-Box® container use at 35 U-Haul centers across Nebraska and Iowa to residents impacted by record rainfall and flooding. In Omaha, intense storms on Wednesday made it one of the city’s wettest days on record. Flash flooding also hit parts of Iowa, with excessive rain prompting warnings in some counties and increasing the threat of river flooding. Many homeowners and businesses...

DALLAS--(BUSINESS WIRE)--Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”) today announced the closing of the previously announced acquisition of Paloma Permian LLC (“Paloma”), a portfolio company of EnCap Investments L.P. (“EnCap”), for cash consideration of $1.255 billion, which amount is subject to customary post-closing adjustments (the “Paloma Acquisition”). Highlights of the Paloma Acquisition include: Adds over 156 net locations (normalized to two-mile laterals) across...

ODENSE, Danimarca--(BUSINESS WIRE)--Grazie alla sua strategia quinquennale Fit to Scale, Orifarm definisce un percorso ambizioso di espansione in Europa, che include un'importante ampliamento della sua attività di farmaci su prescrizione da un modello essenzialmente nordico a una piattaforma europea più vasta. La strategia punta a raddoppiare l'EBITDA fino a €300 milioni di euro e a generare oltre 3 miliardi di euro di entrate entro il 2031, segnando una nuova fase nel percorso di Orifarm in qu...

ODENSE, Denemarken--(BUSINESS WIRE)--Met Fit to Scale, de strategie van het bedrijf voor de komende vijf jaar, stippelt Orifarm een ambitieus pad uit voor schaalvergroting in Europe, met inbegrip van een belangrijke uitbreiding van zijn productenlijn geneesmiddelen op voorschrift van een Scandinavische voetafdruk naar een ruimer Europees platform. De strategie beoogt om EBITDA te verdubbelen naar €300 miljoen en meer dan €3 miljard inkomsten te genereren tegen 2031. Dit markeert de volgende sta...

ODENSE, Dänemark--(BUSINESS WIRE)--Mit seiner Fünfjahresstrategie „Fit to Scale“ legt Orifarm einen ehrgeizigen Kurs für die Expansion in ganz Europa fest, einschließlich eines erheblichen Ausbaus seines Geschäfts mit verschreibungspflichtigen Arzneimitteln von einer nordischen Präsenz hin zu einer breiter aufgestellten europäischen Plattform. Die Strategie zielt darauf ab, das EBITDA bis 2031 auf 300 Mio. Euro zu verdoppeln und einen Umsatz von mehr als 3 Mrd. Euro zu erzielen. Dies markiert d...

ODENSE, Danemark--(BUSINESS WIRE)--Avec sa stratégie quinquennale, Fit to Scale, Orifarm trace une voie ambitieuse pour se développer à l’échelle européenne, notamment grâce à une expansion majeure de son activité de médicaments sur ordonnance, qui passera d’une présence nordique à une plateforme européenne plus large. Cette stratégie vise à doubler le BAIIDA pour atteindre 300 millions d’euros et à générer plus de 3 milliards d’euros de chiffre d’affaires d’ici 2031, marquant ainsi une nouvell...